Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68:988–1001.

Article  CAS  PubMed  Google Scholar 

Jänig W. Integrative action of the autonomic nervous system: neurobiology of homeostasis. Cambridge: Cambridge University Press; 2006.

Book  Google Scholar 

Beissner F, Meissner K, Bär KJ, Napadow V. The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci. 2013;33:10503–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engelhardt E, Laks J. Alzheimer disease neuropathology: understanding autonomic dysfunction. Dement Neuropsychol. 2008;2:183–91.

Article  PubMed  PubMed Central  Google Scholar 

Collins O, Dillon S, Finucane C, Lawlor B, Kenny RA. Parasympathetic autonomic dysfunction is common in mild cognitive impairment. Neurobiol Aging. 2012;33:2324–33.

Article  PubMed  Google Scholar 

Tulbă D, Cozma L, Popescu BO, Davidescu EI. Dysautonomia in Alzheimer’s disease. Med (Kaunas). 2020;56.

Jensen-Dahm C, et al. Autonomic dysfunction in patients with mild to moderate Alzheimer’s disease. J Alzheimers Dis. 2015;47:681–9.

Article  PubMed  Google Scholar 

Royall DR, Gao JH, Kellogg DL Jr. Insular Alzheimer’s disease pathology as a cause of age-related autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses. 2006;67:747–58.

Article  PubMed  Google Scholar 

Valenza G, et al. The central autonomic network at rest: uncovering functional MRI correlates of time-varying autonomic outflow. NeuroImage. 2019;197:383–90.

Article  CAS  PubMed  Google Scholar 

Ding K, et al. Central autonomic network functional connectivity: correlation with baroreflex function and cardiovascular variability in older adults. Brain Struct Funct. 2020;225:1575–85.

Article  PubMed  PubMed Central  Google Scholar 

Nair SS et al. Investigation of autonomic dysfunction in Alzheimer’s disease-a computational model-based approach. Brain Sci. 2023;13.

Nonogaki Z, Umegaki H, Makino T, Suzuki Y, Kuzuya M. Relationship between cardiac autonomic function and cognitive function in Alzheimer’s disease. Geriatr Gerontol Int. 2017;17:92–8.

Article  PubMed  Google Scholar 

Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer’s disease: refining the disconnection hypothesis. Brain Connect. 2014;4:299–311.

Article  PubMed  PubMed Central  Google Scholar 

Sheline YI, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry. 2010;67:584–7.

Article  CAS  PubMed  Google Scholar 

Neufang S, et al. Disconnection of frontal and parietal areas contributes to impaired attention in very early Alzheimer’s disease. J Alzheimers Dis. 2011;25:309–21.

Article  CAS  PubMed  Google Scholar 

Allen G, et al. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007;64:1482–7.

Article  PubMed  Google Scholar 

Wang L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: evidence from resting state fMRI. NeuroImage. 2006;31:496–504.

Article  PubMed  Google Scholar 

Dautricourt S, et al. Longitudinal changes in hippocampal network connectivity in Alzheimer’s disease. Ann Neurol. 2021;90:391–406.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson-Greene D, Dementia Rating Scale-2 (DRS-2) By, Jurica PJ, Leitten CL. and S. Mattis: psychological assessment resources, 2001. Arch Clin Neuropsychol. 2004;19:145–147.

Kapoor A et al. Increased levels of circulating angiogenic cells and signaling proteins in older adults with cerebral small vessel disease. Front Aging Neurosci. 2021;13.

Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–41.

Article  PubMed  Google Scholar 

Nieto-Castanon A. Handbook of functional connectivity magnetic resonance imaging methods in CONN. 2020.

Grothe MJ, et al. Associations of fully automated CSF and novel plasma biomarkers with Alzheimer disease neuropathology at autopsy. Neurology. 2021;97:e1229–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Press, New York, NY, US. 2013, pp. xvii, 507-xvii, 507.

Korthauer K, et al. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 2019;20:118.

Article  PubMed  PubMed Central  Google Scholar 

Mayer CA, et al. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8:e62101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelhak A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Reviews Neurol. 2022;18:158–72.

Article  CAS  Google Scholar 

Amalia L. Glial fibrillary acidic protein (GFAP): Neuroinflammation Biomarker in Acute ischemic stroke. J Inflamm Res. 2021;14:7501–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benedet AL, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 2021;78:1471–83.

Article  PubMed  Google Scholar 

Kim KY, Shin KY, Chang K-A. GFAP as a potential biomarker for Alzheimer’s disease: a systematic review and meta-analysis. Cells. 2023. https://doi.org/10.3390/cells12091309.

Article  PubMed  PubMed Central  Google Scholar 

Chatterjee P, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer’s disease: associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer’s Dement. 2023;19:2790–804.

Article  CAS  Google Scholar 

Pereira JB, et al. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease. Brain. 2021;144:3505–16.

Article  PubMed  PubMed Central  Google Scholar 

Giacomucci G, et al. Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in subjective cognitive decline and mild cognitive impairment. J Neurol. 2022;269:4270–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewczuk P, et al. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease. Alzheimers Res Ther. 2018;10:71.

Article  PubMed  PubMed Central  Google Scholar 

de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen J. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension. 2019;74:1172–80.

Article  PubMed  Google Scholar 

Jarczok MN, et al. Heart rate variability in the prediction of mortality: a systematic review and meta-analysis of healthy and patient populations. Neurosci Biobehav Rev. 2022;143:104907.

Article  Google Scholar 

Rovere MTL, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–84.

Article  PubMed  Google Scholar 

deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol Heart Circ Physiol. 1987;253:H680–9.

Article  CAS